Houweling et al. [31] reported a high lifetime risk of pneumothorax risk (24%) in FLCN mutation carriers with BHD syndrome, which emphasized the importance of early surveillance and management strategies for BHD-associated conditions. This evidence concerns the gene FLCN and Birt-Hogg-Dubé syndrome.